BOOKS
1.
Haynes C, Gillman MA (1992)
Death the Last Great Adventure.
Bizbee, U.S.A: Nomad Press.
2.
Gillman MA (1995)
Stress - The change factor. Bizbee,
U.S.A: Nomad Press.
3. Gillman
MA (1996)
Envy as a retarding force in science.
4. Gillman MA (2004-2005)
Psychotropic Analgesic Nitrous Oxide
(PAN) Sedation 1st Edition – Textbook (in CD form).
5. Gillman MA (2004-2007)
Psychotropic Analgesic Nitrous Oxide
(PAN) Sedation 2nd Edition – Textbook (in CD form).
OTHER
PUBLICATIONS (Articles,
Book Chapters & Letters to The Editor)
1. Gillman
MA, Lichtigfeld FJ (1980) Nitrous oxide: treatment of withdrawal symptoms. Lancet 2: 803.
2. Gillman MA, Kok L, Lichtigfeld FJ (1980)
Paradoxical effect of naloxone on nitrous oxide analgesia in man. Eur J Pharmacol 61: 175-177.
3. Gillman MA, Lichtigfeld FJ (1981) A
comparison of the effect of morphine sulphate and nitrous oxide analgesia on
chronic pain states in man. J Neurol Sci 45: 41-45
4. Gillman
MA, Lichtigfeld FJ (1981) The similarity of the action of nitrous oxide and
morphine. Pain 10: 110
5. Gillman
MA, Kimmel I, Lichtigfeld FJ (1981) The dual system hypothesis of pain
perception. Neurolog Res. 3 : 317-327
6. Gillman MA, Footerman D (1981) The need for
a clearer distinction between anesthesia and analgesia in relation to the
opiate system. Anesthesiology 54: 524
7.
Gillman MA, Lichtigfeld FJ (1981)
Naloxone in Anorexia Nervosa - The role of the opiate system. J. Roy Soc Med
74: 631-632
8. Gillman MA, Lichtigfeld FJ (1981) The
almighty referee. New scientist 90: 644
9. Gillman
MA, Lichtigfeld FJ (1981) Management of alcohol withdrawal symptoms.
10 Lichtigfeld
FJ, Gillman MA (1982) The treatment of alcoholic withdrawal states with oxygen
and nitrous oxide.
11. Gillman MA, Lichtigfeld FJ (1981) The
endorphins and stress.
12. Gillman MA, Lichtigfeld FJ (1981) The opiate
system in traumatic brain death. Lancet 2: 156
13. Gillman
MA, Lichtigfeld (1981) Anorexia nervosa - A stress syndrome.
14. Gillman MA, Lichtigfeld FJ (1981) Naloxone and
cerebral ischaemia. Lancet 2: 643
15. Gillman
MA, Lichtigfeld FJ (1981) Management of alcohol withdrawal symptoms. Brit Med J 283: 674
16. Gillman MA, Lichtigfeld FJ (1981) Cabal of
referees. Nature 291: 608
17. Gillman MA, Lichtigfeld FJ (1981) Solicited
testimonials. New scientist 91: 368
18. Gillman
MA, Footerman DS and Lichtigfeld FJ (1982) Nitrous oxide and anti-stress
agent? Anesthesiology 56: 234-235
19. Gillman
MA, Lichtigfeld FJ (1982) Possible drug differentiation of the psychoses. Am J
Psychiatry 139: 384
20. Gillman
MA (1982) Nitrous oxide at analgesic concentrations an opiate agonist. Further
evidence. Anesth. Analg. 61: 394
21. Gillman MA, Lichtigfeld FJ (1983) The effect
of nitrous oxide and naloxone on orgasm in human females. A Preliminary
report. J.Sex Res 19: 49-57
22. Gillman
MA (1982) The principles of prescribing anti-microbial (anti-biotics)agents in
dentistry. J Dent Assoc S Afr 37:
191-192
23. Gillman MA (1982) Anti-microbial agents used
in dentistry - Part 1. J Dent Assoc S Afr 37: 9 657-658
24. Gillman MA, Lichtigfeld FJ (1982) Oestrogen
and parkinsonism.
25. Gillman MA, Lichtigfeld FJ (1981) The
possibility of an opiate and anti-opiate system. J. Roy Soc Med. 74: 943
26. Gillman MA, Lichtigfeld FJ (1983) Receptor
hypothesis of the alcohol withdrawal state: CNS receptor- from molecular
pharmacology to behaviour. In: advances
in biochemical psychopharmacology V 37
Raven Press
27.
Gillman MA (1984) The possibility that
nitrous oxide at analgesic concentrations is an opiate receptor agonist. J. Soc Adv Anaesth Dent 5: 244-248
28. Gillman MA, Lichtigfeld FJ (1983) Naloxone and
its analeptic effect. Anesthesiology 58:287
29. Gillman MA, Lichtigfeld FJ (1982) Dual system
hypothesis of pain perception: Possible further evidence. Anesth Analg 61:
886-889
30.
Lichtigfeld FJ Gillman MA, (1983) The
treatment of alcoholic withdrawal states with oxygen and nitrous oxide.
31. Gillman MA, Lichtigfeld FJ (1982) Naloxone for
alcohol intoxication. Lancet 2: 558
32. Gillman MA (1982) Possible dangers of naloxone
use J Am Med Assoc 248:2972-2973
33. Gillman
MA, Lichtigfeld FJ (1982) Intraspinal opiates and itching. A New Reflex?
34.
Gillman MA (1982) Anti-microbial agent
used in dentistry - Part 2. J Dent Assoc S Afr 37: 747-750
35. Gillman
MA, Lichtigfeld FJ (1982) Paradoxical effect of naloxone on nitrous oxide
analgesia. Brit J Anaesth 55:
91
36. Gillman
MA, Lichtigfeld FJ (1983) Nitrous oxide interacts with opioid receptors: More
evidence. Anesthesiology 58: 85-86
37. Gillman MA (1982) Anti microbial agent used in
dentistry - Part 3 Therapeutic notes. J Dent Assoc S Afr 38: 18-19
38. Gillman (1982) The safety of nitrous oxide.
Lancet 2: 1397
39. Gillman MA, Lichtigfeld FJ (1983) The opiate
system in Anorexia Nervosia Am J Psychiatry 140:371
40. Gillman MA (1983) On peer review.
41. Daras C, Cantrill RC and Gillman MA (1983) (3H)Naloxone
displacement: evidence for nitrous oxide as opioid receptor agonist. Eur J Pharmacol 89:177-178
42. Gillman MA (1983) Antimicrobial aspects of
treating osteomyelitis of the jaws and maxillo facial fractures. J Dent Assoc S Afr 38: 493
43. Gillman MA, Lichtigfeld FJ (1983) The opiate
and anti-opiate system. Evidence from
involvement in withdrawal responses. Can
Anaesth Soc J 30:564-565
44. Gillman
MA, Lichtigfeld FJ (1983) The effect of naloxone on nitrous oxide analgesia.
45. Lichtigfeld FJ, Gillman MA (1983) Treatment of
alcoholic withdrawal state with oxygen and nitrous oxide. Psychiat Digest (June) pp12-13
46. Lichtigfeld
FJ, Gillman MA (1982) Oxygen or laughing gas for alcohol withdrawal. Medicine
Digest 8: 57
47. Gillman MA, Sandyk R (1984) Parkinsonism
induced by methyldopa.
48. Gillman
MA (1983) Pharmacology of analgesic agent used in Dentistry-Part 1. J Dent Assoc S Afr 38:575-576
49. Gillman
MA (1983) Pharmacology of analgesic agent used in dentistry - Part 2. J Dent Assoc S Afr 38: 697-698
50. Gillman MA (1983) Antibiotic prophylaxis of
infective endocarditis. J Dent Assoc S
Afr 38: 693
51. Gillman MA, Sandyk R (1984) Tourette syndrome:
Effect of analgesic concentrations of nitrous oxide and naloxone. Brit Med J 288: 114
52. Gillman MA, Sandyk R (1984) Haematuria
following tricyclic therapy. Am J Psychiatry 141:463-464
53. Gillman MA, Lichtigfeld FJ, (1983) The
crisis-emergency pharmacotherapy.
54. Gillman MA, Lichtigfeld FJ (1984) An opioid
involvement in Anorexia Nervosa - Further studies needed.
55. Sandyk R, Gillman MA (1983) Chronic
bromocriptine therapy causes urinary incontinence. Lancet 2: 1260-126
56. Gillman
MA, Sandyk R (1984) Bilateral internuclear ophthalmopogia reversed by
naloxone.Arch Neurol 41:703
57. Gillman MA, Lichtigfeld FJ, Sandyk R (1984)
Subacute toxic delirium caused by nitrous oxide may be an acute withdrawal
state. Arch Neurol 41:704
58. Gillman
MA, Sandyk R (1984) Nicotinic acid deficiency induced by sodium valproate.
59. Gillman
MA (1984) Naloxone and its antagonism of anesthesia and analgesia. Can Anaesth Soc. J 31: 117-118
60. Sandyk R, Gillman MA (1986) The opioid system
in the restless legs and nocturnal myoclonus Syndromes. Sleep 9: 370-371
61. Gillman
MA, Sandyk R(1984) Hemifacial spasm - successful treatment with Baclofen.
62. Gillman
MA (1984) The hypertensive response to naloxone - A Commentary.
64. Gillman MA (1984) Possible mechanisms of action
of nitrous oxide at the opioid receptor.
Med Hypotheses 15: 109 - 114
65. Gillman MA, Sandyk R (1984) Nomifensine
exacerbates depression and seizures in an epileptic patient. Neurology 34: 1620
- 1621
66. Sandyk
R, Gillman MA (1985) Transient gilles de la Tourett Syndrome following alcohol
withdrawal. Brit J Addiction 80: 213-214
67. Sandyk R, Gillman MA (1984) Naloxone of no
benefit in levodopa-induced hallucinations in Parkinson's Disease. Ann Neurol 16: 723
68. Sandyk R, Gillman MA (1984) Nor-adrenalin and
tardive dyskinesia. Brit J Psychiatry
145: 217
69. Sandyk R, Gillman MA (1984) Acute exacerbation
of Parkinson's Disease with sulindac. Ann Neurol 17: 104-105
70. Sandyk R, Gillman MA (1984) Blepharospasm
associated with brainstem lesions. Neurology 34:1522-1423
71. Gillman MA, Sandyk R (1985) Reversal of
captopril-induced psychosis with naloxone.
Am J Psychiatry 142: 270,
72. Sandyk
R, Gillman MA (1984) Restless Leg Syndrome associated with amitriptyline.
73. Lichtigfeld FJ, Gillman MA (1985) The
therapeutic uses of opioid substances in psychiatry, with special reference to
analgesic concentrations of nitrous oxide.
Update of psychiatric management, The Society of Psychiatrists SA ed.
J.B. Carlile pp 76 - 79.
74. Gillman MA
Nitrous oxide as an experimental investigative tool in medicine - An
overview. in neuropsychology II, Proceedings of the 2nd
75. Cantrill RC, Wallard DD, Daras C & Gillman
MA Nitrous oxide: Its application in receptor binding studies In Neuropsychology II, Proceedings of the 2nd
S.A. Neuro psychology Conference in
Pretoria 1985 pp. 73 - 82.
76. Gillman MA, Lichtigfeld FJ (1984) The opioid
and anti opioid system in addiction.
77. Sandyk R, Gillman MA (1985) Nomifensine
exacerbates oro-facial dyskinesia in hypothyroidism. neurology 35: 282 1985
78. Sandyk R, Gillman MA (1985) Opioid
hypofunction In Parkinson's Disease. Med
Hypotheses 16: 179-182
79. Sandyk R, Gillman MA (1984) Colchicine
ameliorates constipation in Parkinsonism. J Roy Soc Med 77: 1066
80. Gillman MA, Sandyk R, Lichtigfeld FJ (1984)
Evidence for underactivity of the opioid system in neuroleptic induced
akathisia. Psychiat Res 13: 187
81. Sandyk R, Gillman MA (1987) Baclofen in hemifacial spasm. Int J Neurosci 33: 261-264
82. Gillman MA,
Lichtigfeld FJ (1985) Nitrous oxide acts directly at Mu Opioid
Receptors. Anesthesiology 62: 375
83. Gillman MA (1983) Adventure with nitrous
oxide. Proceedings of the Mine Medical
Officer's Association of
84. Sandyk R, Gillman MA (1985) Nifedipine-induced
psychosis. J Am Geriatric Soc 33: 154
85. Sandyk R, Gillman MA (1985) Naloxone
ameliorates narcolepsy. Clin
Neuropharmacol 8: 96-97
86. Sandyk
R, Gillman MA (1985) Nomifensine exacerbates narcolepsy. Neurology 35:
138-139
87. Gillman MA, Sandyk R (1985) Possible impact of
weekly DST's on thyroid function in patients with affective disorders. Am J Psychiatry 142: 662-663
88. Gillman MA, Lichtigfeld FJ (1986)Minimal
sedation required with nitrous oxide – oxygen treatment of the alcohol
withdrawal state Brit J Psychiatry 148: 604-606
89. Gillman MA, Sandyk R (1985) Opioid induced
unconsciousness reversed by changes in opioid cholinergic and adrenergic
function. J Neurol, Neurosurg & Psychiat 48: 391
90. Sandyk R, Gillman MA (1985) Nomifensine for
emotional incontinence in the elderly. Clin Neuropharmacol 8: 377-378
91. Gillman
MA, Lichtigfeld FJ (1985) Nitrous oxide analgesia and the endogenous opioid
system. Can Anaesth Soc J 32: 200-201
92. Gillman MA (1985) Cholecystokinin dopamine and
the endogenous opioid system in
93. Sandyk R, Gillman MA (1985) Lithium induced
visual hallucinations: Evidence for
possible opioid mediation. Ann Neurol
17: 619-620
94. Sandyk R, Gillman MA (1987) Phenelzine in
migraine headaches. Int J Neurosci 35:
243
95. Sandyk R, Gillman MA (1986) Naloxone causes
urinary urgency. Urology 27: 79
96. Sandyk R, Gillman MA (1985) Baclofen-induced
memory impairment. Clin Neuropharmacol 8: 294-295
97. Gillman MA, Sandyk R (1985) Auto-tolerance to
the endogenous opioids and sleep. medical hypotheses 16: 393-395
98. Sandyk R, Gillman MA (1985) Piracetam causes
confusion in a patient with temporal lobe epilepsy. J Amer Geriatric Soc 33: 305
99. Gillman
MA, Sandyk R (1985) Nitrous oxide ameliorates Spasmodic Torticollis. Eur Neurol 24: 292 - 293
100. Gillman MA, Lichtigfeld FJ (1984) Recovery
after brain injury-some neurotransmitter and clinical implication. Brit J Anaesth 56: 1319
101 Gillman MA (1985) Referees as arbiters of
scientific contributions to the literature.
J Dent Assoc S. Afr 40:
140.
102. Sandyk R, Gillman MA (1985) Depression as a
cause of hallucinations in Parkinson's Disease. Clin Neuropharmacol 8: 199-200
103. Gillman MA, Matussek N and Lichtigfeld FJ Effect of Nitrous oxide on depressive patients
and volunteers, In: Psychiatry: The State of the Art,Vol.2 pp. 397-404 (ed P
Berner) Plenum Publishing New York 1985
104. Gillman MA (1985) Anesthesia and analgesia are
mediated by different mechanisms. Anesth and Analg 64: 752
105. Sandyk R, Gillman MA (1985) Maprotiline in
nocturnal enuresis. J Clin Psychiatry 46: 546
106. Gillman MA, Lichtigfeld FJ (1985) High dose
dihydrocodeine produces hyperalgesia. J
Roy Soc Med 78: 697-698
107. Gillman
MA, Sandyk R (1985) Response to opioids in 3 patients with restless leg
syndrome. Am J Psychiatry 142: 662
108. Gillman MA (1985) Naloxone and
hypertension.
109. Gillman MA (1985) Nitrous oxide as an opioid
and the association between the therapeutic use of narcotics and addiction. Postgrad Med J 61: 653
110. Gillman MA, Lichtigfeld FJ (1985) Analgesic
nitrous oxide : Adjunct to clonidine for opioid withdrawal. Am J Psychiatry 142: 784-785
111. Sandyk R, Gillman MA (1985) Phenytoin toxicity
induced by co-trimoxazole treatment. Ann
Int Med 102: 559
112. Gillman MA (1985) Nitrous oxide and its opioid
emetic properties. Canad Anaesth Soc J
32: 315
113. Gillman MA,
Lichtigfeld FJ (1985) A pharmacological overview of opioid mechanisms
mediating analgesia and hyperalgesia.
Neurological Res. 7:106-119
114. Sandyk R,
Gillman MA (1985) Infantile autism: A dysfunction of the opioids?
Med Hypotheses 19: 41-45
115. Gillman MA,
Sandyk R (1985) Tourette Syndrome and the opioid system. Psychiatry Res
15: 161-162
116. Gillman MA,
Sandyk R (1986) Parkinsonism induced by a monoamine oxidase
inhibitor. Postgrad Med J 62: 235-236
117. Gillman
MA (1986) "Nitrous oxide, an opioid addictive agent" Review of the
evidence. Am J Medicine 81: 92-102
118. Sandyk ,R Gillman MA (1985) Cerebral glucose
utilization in Parkinson's Diseases.
J Neurol Neurosurg
Psychiatry 48: 489
119. Gillman
MA, Lichtigfeld FJ (1985) The endogenous
opioid system and Anorexia Nervosa.
S.Afr. Med J 68: 454
120. Gillman MA (1986) Alcohol improves dystonia:
opioid system involvement? Neurology 36: 303
121. Gillman MA,
Lichtigfeld FJ (1986) The opioids, dopamine cholecystokinin and eating
disorders. Clin Neuropharmacol 9: 91-97
122. Lichtigfeld FJ
Gillman MA (1985) The use of sulphur hyperthermia in cancer. Eur J Surg Oncol 11: 299
123. Gillman MA, Sandyk R (1985) Opiatergic and
dopaminergic function and Lesch Nyhan Syndrome.
Am J Psychiatry 142: 1226
124. Gillman MA (1985) Analgesic nitrous oxide: as
an aphrodisiac. Med Sex J
125. Sandyk
R, Gillman MA (1986) Tardive dyskinesia and glucose metabolism.
Arch Gen Psychiat 43 : 192-3.
126. Gillman MA, Lichtigfeld FJ (1985) Lithium and Bulimia : The role of the
dopaminergic and opiatergic system. Am
J. Psychiatry 142 :1522-3.
127. Gillman
MA, Lichtigfeld FJ (1986) Is nitrous
oxide the primordial opioid substance? S. Afr. J Sci 82: 10
128. Gillman MA,
Lichtigfeld FJ (1986) Naloxone morphine synergism : Support for dual system Hypothesis of pain perception. Anesth Analg 65: 313
129. Gillman
MA (1986) Toxicity of bone marrow in dentists exposed to nitrous oxide.Br Med J
291: 1052
130. Gillman MA, Lichtigfeld FJ (1986)
Buprenorphine-naloxone synergism :
Evidence for dual system hypothesis of pain perception. anaesthesia 41:
211
131. Gillman MA, Sandyk R (1986) The endogenous
opioid system in Gilles De La Tourette Syndrome. Med Hypotheses 19: 371-378
132. Gillman MA, Lichtigfeld FJ (1986) The paradox
of naloxone. Brit J Anaesth 58:
572
133. Gillman MA (1985) The use of nitrous oxide in
investigating neurological disorders. Progress in Clinical Neuroscience Vol
2 Ed K.K. Sinha Neurological Society of
134. Gillman MA,
Lichtigfeld FJ (1985) Anaesthesia and alcohol. Brit Med J. 291: 1505-1506
135. Sandyk R,
Gillman MA (1986) Amitriptyline for pain of cortical origin. Clin Pharmac 5: 108
136. Gillman
MA, Lichtigfeld FJ (1986) Synergism by
spironolactone and lithium in mania.
Brit Med J. 292: 661
137. Gillman MA, Lichtigfeld FJ (1986) The opioids
and the GABA-ergic differentiation of the psychoses.
138. Gillman MA (1986) The safety of nitrous
oxide. J Am Dent Assoc 112: 12
139. Gillman MA (1986) Pharmacokinetic differences
could explain the lack of reversal of nitrous oxide analgesia by low dose
naloxone. Anesthesiology 65: 449
140. Gillman MA, Lichtigfeld FJ (1986) Hyperalgesic
opioid system. S Afr J Sci 82: 402
141. Sandyk R, Bamford C, Iacono RP, Gillman MA
(1987) Cerebral cysticercosis presenting as progressive dementia. Int J Neurosci 35: 251-254
142. Sandyk
R, Bamford CR, Gillman MA (1987) Clinical note : Opiates in the Restless Legs
Syndrome. Int J Neurosci 36: 99-104
143. Sandyk R, Bamford CR, Iacono RP, Consroe
PF, Gillman MA (1988) The
electromyographic silent period is reduced in individuals at risk for
Huntington's Disease. Int J Neurosci 40: 109-110
144. Sandyk R, Gillman MA, Iacono RP, Bamford CR (1987) Clonidine in
neuropsychiatric disorders: A Review. Int J. Neurosci 35:205-215
145. Gillman MA (1986) Analgesic (Sub Anesthetic)
Nitrous oxide interacts with the endogenous opioid system: A review of the
evidence. Life Sci. 39: 1209 - 1222
146. Lichtigfeld FJ, Gillman MA, Sandyk R (1988)
New vistas in chronic schizophrenia. Int J Neurosci 38: 355-367
147. Gillman MA, Lichtigfeld FJ (1986) Analgesic
actions of naloxone suggest the presence of an hyperalgesic opioid system.
148. Sandyk R,
Gillman MA (1987) Clonazepam-induced Tourette's Syndrome in a subject
with hypereflexia. Postgrad Med J 63:
311-312
149. Gillman
MA 1987 Editorial - Haematological changes caused by nitrous: Cause for
concern? Brit J Aneasth 59: 143-147
150. Gillman MA 1987 Substance abuse and the
media.
151. Gillman
MA, Lichtigfeld FJ (1987) Central
beta-endorphin release by nitrous oxide.
J Oral
Max-Fac Surg 45: 472, 515
152 Gillman MA, Lichtigfeld FJ (1987) Nitrous
oxide analgesia is potentiated by low dose of naloxone : More possible evidence of an hyperalgesic
opioid system. S Afr J Sci 83:
560-563
153. Saffey K, Gillman MA, Cantrill R (1988)
Chronic in vivo ethanol administration alters the sensitivity of adenylate
cyclase coupling in homogenates of rat brain.
Neur Sci Let 84: 317-322
154. Gillman
MA (1988) Anti-neoplastic synergism of nitrous oxide and methotrexate.
Brit J Anaesth 60: 349-350
155. Gillman MA, Katzeff IE (1988) Does opioid
uncoupling of adrenal responses mediate opioid anti-stress effects? Med Sci Res 16: 207 - 209
156. Gillman MA, Katzeff IE, Vermaak WJH, Becker
PJ,Susani E Hormonal responses to analgesic nitrous oxide in man. Horm Metab
Res 20:751-754 (1988)
157. Gillman MA (1988) Assessment of the effect of
analgesic concentrations of nitrous oxide on human sexual response. Int J Neurosci 43: 27-33
158. Gillman
MA, Lichtigfeld FJ (1988) Pellagra prevention project. S Afr J Sci 84:
148-149
159. Gillman MA (1988) Inhalation sedation with
isoflurane: An alternative to nitrous oxide sedation in dentistry. Brit Dent J 164: 204
160. Gillman
MA (1988) Folinic acid prevents megaloblastic changes associated with nitrous
oxide. Anesth Analg 67: 1018
161. Gillman MA (1988) Smoking in airliners. Lancet 1: 1054
162. Dafny N, Gillman MA. Lichtigfeld FJ (1988)
Cholecystokinin: induced suppression of feeding in fed, fasting and
hypothalamic island rats. Brain Res Bull
21: 225-31
163. Gillman
MA (1988) Isoflurane :An appropriate alternative to analgesic nitrous oxide?
Br J Anaesth
61: 517-518
164. Gillman
MA (1988) Analgesic nitrous oxide an unlikely trigger for malignant
hyperthermia. J Dent Assoc S Afr 43: 425
165. Gillman MA (1988) The Data explosion. Nature 333 : 698
166. Gillman MA (1988) Analgesic nitrous oxide:
Focus of the South African Brain Research Institute's Research. MRC News 19:
10-11
167. Gillman MA, Lichtigfeld FJ (1988) Polydidpsia
in psychosis S Afr Med J 74: 536
168. Gillman MA (1988) Orthodoxy and
Homeopathy. Nature 335: 292
169. Gillman MA (1988) Disadvantages of air-oxygen
mixtures replacing nitrous oxide. Anaesthesia 43: 898-899
170. Lichtigfeld FJ, Gillman MA (1989) The effect
of placebo in the alcohol withdrawal state.
Alc Alcohol 24: 109-112
171. Gillman MA (1989) Analgesic nitrous oxide for
addictive withdrawal states.
172. Gillman MA. Shevel J Analgesic nitrous oxide
and oxygen for acute withdrawal from cigarette smoking. Proceeding of drug and alcohol research
forum. Broederstroom; January 1988 pp. 66-74
173. Gillman MA (1989) Replacing analgesic nitrous
oxide with a dangerous alternative. Anesthesia 44: 255-256
174. Gillman
MA (1989) Nitrous oxide and hypoxia : Is it the gas or the user? Anaesthesia 44: 257
175. Gillman MA (1989) Further evidence that
analgesia and anesthesia are mediated by differing mechanisms. Anesth Analg 68: 186
176. Lichtigfeld FJ, Gillman MA (1990) Dangerous
synergism between sedatives and a hyponatraemic state. J Roy Soc Med 83: 185
177. Gillman MA, Lichtigfeld FJ (1989) Analgesic
nitrous oxide in neuropsychiatry: Past, present future. Int J Neurosci 49: 75-81.
178. Lichtigfeld FJ, Gillman MA (1989) Analgesic
nitrous oxide for alcohol withdrawal is better than placebo. Int J Neurosci 49: 71-74
179. Gillman
MA, Katzeff IE (1989) Anti-stress hormonal responses of analgesic nitrous
oxide. Int J Neurosci 49: 199-202
180. Gillman
MA (1989) Physico-chemical basis of nitrous oxide activity at opioid
receptors. S Afr J Sci 85: 280-281
181. Gillman MA (1989) SABRI's Pellagra prevention
project - A year of Progress. S Afr J
Sci 85: 214
182. Lichtigfeld
FJ, Gillman MA (1989) Unique neurological signs in Wernicke's
encephalopathy?
183. Gillman MA, Lichtigfeld FJ (1989) Naloxone
analgesia : update Int J Neurosci 48:321-324
184. Gillman MA (1989) Different mechanisms may
mediate anaesthesia and analgesia. Can J Anaesthesia 36: 734-735
185. Lichtigfeld FJ, Gillman MA (1991) In spite of
its validity has Dale's principle served its purpose? - A scientific
paradox. Perspect Biol Med 34: 239 - 253
186. Lichtigfeld
FJ, Gillman MA (1990) Unique neurological signs in Wernicke's encephalopathy?
(II) S Afr Med J 77: 485-486
187. Gillman MA, Lichtigfeld FJ (1990) Analgesic
nitrous oxide for alcohol withdrawal : A critical appraisal after 10 years
use. Postgrad Med J 66: 543-546
188. Lichtigfeld
FJ, Gillman MA (1991) A fatal association between a seizure and drug induced
Parkinsonism. J Roy Soc Med 84: 237-238
189. Gillman MA (1990) Opioid action of analgesic
nitrous oxide. Ann Emerg Med 19:160/843-161/844
190. Gillman
MA (1990) Analgesic nitrous oxide as an investigative and therapeutic agent in
psychiatry Int J Neurosci 53:231-233
191. Gillman MA, Lichtigfeld FJ (1990) Naloxone
analgesia : Further developments Int J
Neurosci 52: 3-4
192. Gillman MA, Lichtigfeld FJ (1991) The opioid
effects of analgesic (Subanesthetic) nitrous oxide on the alcohol withdrawal
state. Ann N Y Acad Sci 625: 784- 785
193. Gillman
MA, Lichtigfeld FJ (1990) The drug
management of severe alcohol withdrawal syndromes Post Graduate Med J 66: 1005-1009
194. Lichtigfeld FJ, Gillman MA (1990)
Methylphenidate for reversal of drug-induced coma Clin Neuropharmacol 13:
459-460
195. Gillman MA, Lichtigfeld FJ (1991) Is there a
linkage between the action of nitrous oxide and melatonin? Int J Neurosci 56: 207-208
196. Gillman MA (1991) Are claims of false priority
scientific misconduct or just evidence only of bad manners? S Afr J Sci 87:20 -
21
197 Lichtigfeld
FJ, Gillman MA(1991)Combination therapy with carbamazepine/benz-odiazepine for
polydrug analgesic/depressant withdrawal.
J Subst Abuse Treat 8: 293 - 295
198. Gillman MA (1991) Dimethylthiourea not
necessary to prevent the effect of nitrous oxide inactivation of methionine
synthase Brit J Anaesth 66: 274-275
199. Gillman MA (1991) Safety of nitrous oxide in
association with sepsis.
200. Lichtigfeld FJ, Gillman MA (1991) Advances in
understanding alcohol withdrawal states.
Post Graduate Med J 67: 700-701
201.
Gillman MA, Lichtigfeld FJ (1991) Placebo and analgesic nitrous oxide for
treatment of the alcohol withdrawal state.
Brit J Psychiatry 159:
672-675
202. Gillman MA 1991 Calcium hydroxide and sporadic
clinical mycotoxicosis J Nutr 7: 199-200
203. Gillman
MA, Lichtigfeld FJ (1991) Impartiality of the South African Medical and Dental
Council.
204. Gillman MA (1991) The Role of gases in
neurotransmission S Afr J Sci 87: 573
205. Gillman MA, Lichtigfeld FJ (1992) Neuroleptics
in alcohol withdrawal S Afr Med J 81: 45
206. Gillman MA, Lichtigfeld FJ (1992) Neuroleptics
in alcohol withdrawal S Afr Med J 81:
387
207. Gillman MA (1991) Sex and the ageing. Med
Sex J
208. Lichtigfeld FJ, Gillman MA (1992) The opioid
system and the placebo response Amer J Psychiatry 149: 276
209. Gillman MA, Lichtigfeld FJ (1992) Abuse of
neuroleptic drugs? Brit J Addiction 87:
937
210. Gillman MA (1992) One more cook stirring the
maize pot. J Nutr Health 8: 231
211. Gillman MA (1992) Drug education and the media.
Nursing RSA 7: 26-27
212. Gillman
MA (1992) Nitrous oxide abuse in perspective Clin Neuropharmacol 15: 297 - 306
213. Gillman MA, Is Premenstrual Syndrome a mini
burn-out syndrome?
214. Sandyk R, Kay SR, Gillman MA (1992) The role of
melatonin in the antipsychotic and motor-side effects of neuroleptics: a
hypothesis. Int J Neurosci 64 : 203-207
215. Gillman MA (1992) Media statements by drug
experts can be dangerous Nursing RSA 7:
19-20
216. Gillman MA (1993) Analgesic nitrous oxide
should join the opioid family after almost two centuries. S Afr J Sci 89: 25 - 27
217. Gillman MA (1992) Nitrous oxide as
neurotransmitter. Lancet 339 : 307
218. Gillman MA, Lichtigfeld FJ (1993)
Opioid/autonomic links in disease J
Rheumatol 20: 1083 -1084
219. Lichtigfeld FJ, Gillman MA (1994) Possible
abuse of and dependence on major tranquilizers and tricyclic
antidepressants.
220. Gillman MA (1993) Nitrous oxide at homeopathic
doses. J Roy Soc Med 86 : 309 - 310
221. Gillman MA (1992) Nitrous oxide, Nitric oxide
and neurotransmission. Brit Med J 305: 1368
222. Lichtigfeld FJ, Gillman MA (1992)
Tranylcypromine abuse: cause for concern. Am J Psychiatry 149: 989
223. Lichtigfeld FJ,
Gillman MA (1994) Psychotropic analgesic nitrous oxide and neurotransmitter
mechanisms involved in the alcohol withdrawal state. Int J Neurosci 76: 17-33
224. Gillman MA, Lichtigfeld FJ (1994) Pharmacology
of psychotropic analgesic nitrous oxide as a multipotent opioid agonist. Int J Neurosci 76: 5-12
225. Ojutkangas R, Gillman MA (1994) Psychotropic
analgesic nitrous Oxide for treating alcohol withdrawal in an outpatient
setting. Int J Neurosci 76: 35-39
226. Gillman MA (1994) Psychotropic analgesic
nitrous oxide as an investigative, diagnostic and therapeutic tool. Int J Neurosci 76: 1-3
227. Daynes G, Gillman MA (1994) Psychotropic
analgesic nitrous oxide prevents craving after withdrawal from alcohol,
cannabis and tobacco. Int J Neurosci 76: 13-16
228. Gillman MA, Lichtigfeld FJ (1994) NO comments.
Nature 367: 28
229. Gillman MA, Lichtigfeld FJ (1994) Opioid
properties of psychotropic analgesic nitrous oxide (Laughing Gas). Perspect Biol Med 38: 125-138
230. Gillman MA (1994) Analgesic nitrous oxide for
addictive withdrawal.
231. Gillman MA, Lichtigfeld FJ (1995) Opioid effects of psychotropic analgesic
nitrous oxide on the dopaminergic system.
Anesth Analg 80: 855-6
232. Gillman MA (1995) Nitrous oxide has a very low
abuse potential. Addiction 90: 439
233. Gillman MA (1994) Diagnosis and therapy with
psychotropic analgesic nitrous oxide. The Leech 63: 51-54
234. Gillman MA, Lichtigfeld FJ (1994) The uses of
analgesic nitrous oxide in neuropsychiatry.
235. Lichtigfeld FJ, Gillman MA (1996) Role of
dopamine mesolimbic system in opioid action of psychotropic analgesic nitrous
oxide (PAN) in alcohol and drug withdrawal. Clin Neuropharmacol 19: 246-50
236. Gillman MA (1996) Alternative approach to the
treatment of addictive withdrawal. S Afr J Sci 92: 184
237. Gillman MA, Lichtigfeld FJ (1995) Analgesic
nitrous oxide effective for addictive withdrawal states? Psychiatry in Practice
p16-17 Sept/October.
238. Gillman MA, Lichtigfeld FJ (1996) Effect of
naloxone on nitrous oxide analgesia. Brit J Anaesth 77: 435-36
239. Gillman MA, Lichtigfeld FJ (1996)
Pathophysiology of itching. Lancet 348:
1513
240. Gillman MA, Lichtigfeld FJ (1997) Provisional
registration of useful treatments. Lancet 349: 436-37.
241 Gillman MA (1997) Science and emotions Nature
386: 14.
242. Gillman MA, Lichtigfeld FJ (1997) The current
status of analgesic nitrous oxide for treating alcoholic withdrawal
states. Finnish Med J (Suomen
Laakarilehti) 52: 1055-58.
243. Gillman MA, Lichtigfeld FJ (1997) Industry and
science. Addiction 92: 1035
244. Gillman MA, Lichtigfeld FJ (1997) Provisional
registration of useful treatments. Lancet 350: 737
245. Gillman MA, Shevel J (1997) Analgesic nitrous
oxide and oxygen for acute withdrawal of cigarette smoking. Proceedings
International Conference on Tobacco Smoking.
246. Gillman MA, Lichtigfeld FJ (1998) Clinical role
and mechanisms of action of analgesic nitrous oxide. Int J Neurosci 93: 55-62.
247. Gillman MA, Lichtigfeld FJ (1998) A common pathway for addictions? S Afr J Sci 94: 178.
248. Lichtigfeld FJ, Gillman MA (1998)
Antidepressants are not drugs of
abuse or dependence. Postgrad Med J 74:
529-532.
249. Gillman MA, Lichtigfeld FJ (1998) Life-saving
pills. New Scientist 159:49.
250. Gillman MA, Lichtigfeld FJ (1998) Opioid properties
of antidepresants prevention &
treatment 1: http://journals.apa.org/prevention/volume
1/com0010001a.html
251. Gillman MA (1999) Human passions and attribution in
the history of science. Book Review. The birth of the Cell by H Harris. Lancet 353: 1533-34.
252. Lichtigfeld FJ,
Gillman MA. (2000) Violence and the provision of community
psychiatry. Lancet 355: 1804.
253. Gillman MA,
Lichtigfeld FJ. (2000) Analgesic nitrous oxide: an
opioid treatment for migraine Am J Emerg Med. 18: 501.
254. De Wet J, Lichtigfeld FJ, Gillman
MA. (2001) Psychotropic
analgesic nitrous oxide (PAN) for hyperactivity. Aust New
255. Lichtigfeld FJ,
Gillman MA. (2001) Episodic dyscontrol: Relationship to Limbic Ictus and the
underlying neurotransmitters Brain
Pharmacol 1, 59-72
256. Gillman MA (2001)Dark motives, Dark remedy. Book Review; Dark remedy. The impact of
thalidomide and its revival as a vital medicine. by T Stephens, R. Brynner
Lancet 357 : 1893.
257. Lichtigfeld FJ, Gillman MA. (2002). Possible role of the endogenous
opioid system in the placebo response in depression. Int J Neuropsychopharmacol 5: 107-8
258. Lichtigfeld FJ, Gillman MA. (2002). Role of the
amygdala in addictive withdrawal Brain Pharmacol 1:189-196.
259.
Gillman MA, Lichtigfeld FJ. (2002). Randomised double-blind trial of
psychotropic analgesic nitrous oxide compared with diazepam for alcohol
withdrawal state. J Subst Abuse
Treat 22: 129-134.
260.
Gillman MA (2002). Over cautiousness can be a disservice.
261.
Gillman MA (2002). No assumptions for safe nitrous oxide sedation.
JADA
133: 1318,1320.
262. Lichtigfeld FJ, Gillman MA. (2003). Another
marker for depression. Int J
Neuropsychopharmacol 6: 91-2.
263. Gillman, M.A., & Lichtigfeld, F.J. (2004)
Enlarged double-blind randomised trial of benzodiazepines against psychotropic
analgesic nitrous oxide for alcohol withdrawal Addictive Behaviors 29:
1183-1187.
264. Gillman MA, Lichtigfeld FJ. (2004). Correct
use of analgesic nitrous oxide for the alcohol withdrawal state essential. Clin
Psychopharmacology 24: 238-239
265. Gillman MA, Lichtigfeld FJ. (2004). Further
comments on the effects of nitrous oxide treatment on alcohol withdrawal. J
Clin Psychopharmacol 24:473-475.
266. Gillman MA. (2004). Psychoneuroimunology is
an offshoot of Selye’s pioneering work on stress. S Afr J Sci 99: 428.
267. Gillman MA (2004). Conscious sedation.
268. Gillman MA. (2004). Most effective method in
routine conscious sedation for ambulatory patients.
269. Gillman MA. (2004). Conscious sedation.
270. Gillman MA. (2004). Discovery of
gasotransmission. The Scientist 18: 10
271. Gillman MA & Lichtigfeld FJ (2004) An
incorrect technique guarantees failure. Alc Clin Exp Res 28: 1273-1274.
272. Gillman MA. (2004) Nitrous oxide sedation
without adequate scavenging. (2004). S Afr Dent J 60: 68/77.
273. Gillman MA, Lichtigfeld FJ, Young T.
Psychotropic analgesic nitrous oxide for alcoholic withdrawal states. Cochrane
Protocol The Cochrane Library 2005,
Issue 2.
274. Gillman MA, Lichtigfeld FJ. (2006) Psychotropic analgesic nitrous oxide (PAN) as a
probe of the endogenous opioid system in man and for treating substance abuse
withdrawal In: L.A. Bennet (Ed.), New Topics in Substance Abuse Treatment, (pp.
1-72).New
275.
Gillman MA. Introduction: In memoriam:
FJ Lichtigfeld. Int J Neurosci 116: 827 - 833
.
276.
Gillman MA. (2005) Safety of using
nitrous oxide for conscious sedation in asthmatic patients.
277.
Gillman MA. (2006) Psychotropic analgesic
nitrous oxide for addictive withdrawal. Chinese J Drug Depend 14: 73-4.
278.
Gillman MA. (2006) It is illegal and
unethical to use nitrous oxide/oxygen conscious sedation without
scavenging S Afr Dent J 61: 302 .
279.
Gillman MA, Lichtigfeld FJ, Harker N. (2006) Psychotropic analgesic nitrous oxide for
acute cocaine withdrawal in man. Int J Neurosci 116: 847-57.
280.
Gillman MA, Harker N, Lichtigfeld FJ.
(2006) Combined cannabis/methaqualone
withdrawal treated with psychotropic analgesic nitrous oxide. Int J Neurosci
116: 859 - 869.
281.
Gillman MA, Lichtigfeld FJ. Nitrous
oxide and carbon dioxide are both biologically and structurally similar. S Afr
J Sci (in press).
282.
Gillman MA. (2006). Editorial: It is
illegal and unethical to use nitrous oxide/oxygen conscious sedation without
scavenging.
283.
Gillman MA. Safety of using nitrous
oxide for conscious sedation in diabetic patients.
284.
Gillman MA, Lichtigfeld FJ, Young T.
Psychotropic analgesic nitrous oxide for alcoholic withdrawal states. Cochrane
Review. The Cochrane Library (in press).
285.
Gillman MA, Lichtigfeld FJ, Young T. (2007) Psychotropic analgesic nitrous oxide for alcoholic withdrawal states. (Review). The Cochrane Library, Issue 2.
286.
Gillman MA. (2007) Giving up smoking. Quest 4: 40.
287.
Gillman MA. (2008) Editorial: Tobacco cessation and nitrous oxide/oxygen sedation. SA DJ 63: 66.